ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
67.721,30
-0,01%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. MEI Pharma Inc (MEIP)

  7. MEI Pharma Inc (MEIP) News

MEIP

MEI Pharma (MEIP)

MEI Pharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MEIP
DatumZeitQuelleÜberschriftSymbolFirma
21/05/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
21/05/202419h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
20/05/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
09/05/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
09/05/202422h02Business WireMEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
09/05/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
11/04/202414h02Business WireMEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344NASDAQ:MEIPMEI Pharma Inc
11/04/202414h00Business WireMEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer PatientsNASDAQ:MEIPMEI Pharma Inc
10/04/202414h00Business WireMEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:MEIPMEI Pharma Inc
26/03/202413h00Business WireMEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid LeukemiaNASDAQ:MEIPMEI Pharma Inc
29/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MEIPMEI Pharma Inc
21/02/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
20/02/202423h33Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MEIPMEI Pharma Inc
13/02/202423h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
13/02/202423h05Business WireMEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
17/01/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
16/01/202423h00Business WireMEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024NASDAQ:MEIPMEI Pharma Inc
12/01/202422h00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MEIPMEI Pharma Inc
12/01/202422h00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MEIPMEI Pharma Inc
26/12/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
22/12/202322h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
21/12/202303h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
21/12/202303h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
18/12/202322h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
11/12/202322h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
11/12/202318h00Business WireMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023NASDAQ:MEIPMEI Pharma Inc
15/11/202302h59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
09/11/202322h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
09/11/202322h05Business WireMEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
09/11/202322h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:MEIP

Kürzlich von Ihnen besucht

LSE
AQT1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten